Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Lenalidomide After Allo Transplant [Phase 1]
A Phase 1 trial of lenalidomide after allogeneic transplant in patients with multiple myeloma or lymphoma was terminated. The update provide…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma [Phase 2]
Phase 2 study evaluating autologous expanded natural killer cell therapy in asymptomatic multiple myeloma has completed enrollment and poste…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 study evaluating daratumumab in combination with lenalidomide and dexamethasone in relapsed or relapsed-refractory multiple myelom…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma [Phase 2]
A completed Phase 2 clinical trial evaluating expanded natural killer cell therapy for multiple myeloma, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma [Phase 2]
Phase 2 study evaluating Decadron, Biaxin, and pomalidomide in relapsed/refractory multiple myeloma has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating rasburicase to prevent graft-versus-host disease in patients undergoing donor stem cell transplantation; the stud…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies [Phase 1]
A Phase 1 clinical trial update reports the completion of a study evaluating intravenously administered SNS-032 in patients with advanced B-…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [Phase 2]
Phase 2 clinical trial evaluating nonmyeloablative allogeneic stem cell transplantation for various hematologic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma [Phase 1, Phase 2]
The Phase 1/2 study of ACY-1215 alone and in combination with bortezomib and dexamethasone for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy [Phase 1]
This Phase 1 trial update reports on transplantation using specially treated bone marrow for hematologic cancers that have not responded to …
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant [Phase 2]
A Phase 2 study assessing the combination of bortezomib and vorinostat in multiple myeloma patients after autologous stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy [Phase 2]
This update reports results from a Phase 2 study evaluating bendamustine, bortezomib, and dexamethasone (BBD) as first-line therapy for mult…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma [Phase 2]
A Phase 2 study evaluating a four-drug regimen of carfilzomib, clarithromycin, lenalidomide, and dexamethasone for multiple myeloma has resu…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001) [Phase 1]
Phase 1 dose-escalation trial of dalotuzumab (MK-0646) in advanced solid tumors and multiple myeloma completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
The trial evaluating Retacrit (epoetin zeta), a biosimilar, for chemotherapy-induced symptomatic anemia in hematology and oncology has compl…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers [NA]
This entry reports a completed clinical trial evaluating psychoeducational and behavioral strategies to reduce distress and anxiety in patie…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: HD Melphalan and SCT in Patients With IGDD or LCDD [Phase 2]
Phase 2 trial evaluating high-dose melphalan with autologous stem cell transplant in patients with multiple myeloma, including those with IG…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
This document reports results from a Phase 2 trial of infusional carfilzomib in patients with relapsed or refractory multiple myeloma. The s…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates [Phase 2]
Phase 2 clinical trial update assessing bone marker responses in multiple myeloma patients treated with aminobisphosphonates; results have b…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Multi-day Doses in Prevention of Nausea and Emesis [Phase 2]
Phase 2 trial evaluating multi-day dosing to prevent nausea and emesis in patients with multiple myeloma and lymphoma. The study completed a…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma [Phase 2]
Phase 2 safety study of daratumumab (HuMax-CD38) in multiple myeloma has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1-2 trial evaluating amrubicin in combination with lenalidomide and weekly dexamethasone in relapsed/refractory multiple myeloma has c…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial investigating bendamustine plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: ATRA, Celecoxib, and Itraconazole as Maintenance [Phase 1]
A Phase 1 trial evaluated maintenance therapy with a triplet of ATRA (all-trans retinoic acid), celecoxib, and itraconazole in relapsed mult…